Outpatient Use of Antimicrobials in Patients With Rheumatoid Arthritis Before and After Treatment With Tumor Necrosis Factor Inhibitors: A Nationwide Retrospective Cohort Study. Issue 2 (29th November 2021)

• Record Type: Journal Article
• Authors: Bjornsson, Aron H.; Palsson, Olafur; Kristjansson, Mar; Gunnarsson, Petur S.; Grondal, Gerdur; Gudbjornsson, Bjorn; Love, Thorvardur J.
• Is Part Of: ACR open rheumatology. Volume 4:Issue 2(2022)
• Page Start: 187
• Page End: 194
• Publication Date: 2021-11-29
• Subjects: Rheumatology -- Periodicals; 616.723005
• DOI: 10.1002/acr2.11382
• Languages: English
• ISSNs: 2578-5745

Abstract

Abstract : Objective: The objective of this study was to investigate the effect of tumor necrosis factor α inhibitor (TNFi) initiation on the use of antimicrobials among biologic‐naïve patients with rheumatoid arthritis (RA). Methods: Information on all biologic‐naïve patients with RA was extracted from ICEBIO, a nationwide registry. Each patient was matched on age, sex, and calendar time to five randomly selected individuals from the general population. All filled antimicrobial and glucocorticoid prescriptions in the 2 years before and after initiation of the first TNFi were extracted from the Prescription Medicines Register. Prescriptions were quantified by using the number of filled prescriptions (NP) and defined daily doses. Results: We extracted information on 359 patients with RA and 1795 comparators. During the 24 months before initiating treatment with TNFi, patients with RA received more prescriptions for antimicrobials than their matched general population comparators (mean ± SD: 2.8 ± 3.4 vs 1.6 ± 2.7; P < 0.001). The 24‐month mean NP for patients with RA increased to 3.5 ± 3.9 ( P < 0.001) after initiating TNFi: antibiotics, 2.6 ± 3.2 to 3.2 ± 3.5 ( P < 0.001); antivirals, 0.06 ± 0.5 to 0.16 ± 0.7 ( P = 0.004); and antimycotics, 0.14 ± 0.5 to 0.22 ± 0.9 ( P = 0.06). The 12‐month mean NP was highest in the second year after TNFi initiation (1.9 ± 2.4). No association was found between NP and glucocorticoids, age, body mass index, or pre‐TNFi Disease Activity Score 28‐joint count and C‐reactive protein. Conclusion: Patients with RA on TNFi are more commonly treated for infections in the outpatient settings than previously reported. Patients are prescribed more antimicrobials in the 2 years preceding TNFi initiation than the general population, and this use further increases after initiation of TNFi. In contrast to what is reported for infections requiring hospitalization, outpatient antimicrobial use remained elevated for at least 2 years.